HIV Prevention Drug–the Proud Study Results

Last week, the Guardian published an article focusing on the extremely positive findings of the Proud study in the UK, a study designed to evaluate the impact of pre-exposure prophylaxis (PrEP) on preventing HIV infection. This study found an 86% reduction in HIV transmission for individuals taking PrEP (Truvada is the brand name), which is hugely significant.

Read the entire article here.

Share Post